4 Best Pharmaceutical Stocks to Buy in 2023 | The Motley Fool
Abbvie: is it undervalued?
has made a decent recovery this year, jumping 11% YTD.
But it doesn’t have translated to Wall Street, it trades at a valuation even lower than the average price-earnings ratio of the industry.
An undervalued giant of this kind could be a solid investment play as it grows its revenue base.
I’ve been thinking this more as a long term investment.
Abbvie dividends increase to 4.3%
$ABBV has been on my radar and recent earnings beat showing promising signs. Their main drug Humina has some competition now in the U.S. market after 2 rivals getting FDA approval, as a result sales have decreased recently. But their Botox treatments and their other drugs such as Skyrizi and Rinvoq have increased over 50% in sales.
What do you guys think of it?
Also are there any other pharma stocks that you follow for dividends? I'm recently looking for dividend stocks outside of energy, retail and banking sector so any ideas are welcome.
Top Pharmaceutical Stocks to Consider for Long-term
4 Best Pharmaceutical Stocks to Buy in 2023 | The Motley Fool